Skip to content 
8/12 Rapid growth of the NB variant.1.8.1
Virologist Bruno Lina explained that the variant could have a growth advantage, as it penetrates cells faster and reproduces more efficiently. These characteristics could make NB.1.8.1 the dominant variant in the future, although more research is needed to confirm these hypotheses.
9/12 Surveillance of the NB.1.8.1
The surveillance of this variant by the WHO has revived memories of the emergence of SARS-CoV-2, the origin of which remains uncertain. Global health authorities are calling for vigilance, while reminding that current vaccines are still an effective defense against severe forms of the disease.
10/12 Global monitoring of the NB.1.8.1
Scientists around the world are closely monitoring the evolution of NB.1.8.1, seeking to fully understand its potential impact on public health. Although the variant is not yet dominant, its rapid progression and worrying mutations warrant sustained attention.
11/12 Dynamic situation of the NB.1.8.1
variant The WHO stressed that current data do not show that NB.1.8.1 causes more severe disease than other circulating variants. However, the situation remains dynamic, and health authorities continue to closely monitor developments.
12/12 Continued surveillance of the NB.1.8.1 variant
In conclusion, although the NB.1.8.1 variant is not yet a major threat, its rapid spread and mutations require continued surveillance. Vaccines remain our best defence, and public health measures must be strengthened to limit its spread.